Cheniere says avoiding Panama Canal for longer LNG routes to Asia

Must read

Gilead Sciences on track to snap its six-day winning streak

Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....

AbbVie shares set for seventh straight session of gains

AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...

Meta Platforms on track to snap six-day red streak

Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...
LNG tanker is passing by Singapore Strait.

IgorSPb/iStock via Getty Images

Cheniere Energy (NYSE:LNG) said Monday it is shunning the Panama Canal to transport liquefied natural gas to Asia, as a months-long drought has led to delays and depth restrictions for the largest ships accessing the canal.

“We use the canal when it is economical to do so [but] right now it is not,” Cheniere (LNG) COO Corey Grindal said, according to Reuters. “Right now the market in the Far East is not supporting it, and the waiting time, with us not being a priority customer, is just not worth us using it right now.”

Other routes to Asia include sailing through the Suez Canal or a month-long journey around South Africa’s Cape of Good Hope.

Cheniere (LNG) expects to benefit from a growing Asian market with increased demand from countries in South and Southeast Asia, COO Anatol Feygin said.

The COO said China will be the world’s top LNG buyer this year, after importing 64M metric tons last year, and likely rising to 100M tons/year in the future.

More on Cheniere Energy:

More articles

Latest article

Gilead Sciences on track to snap its six-day winning streak

Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....

AbbVie shares set for seventh straight session of gains

AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...

Meta Platforms on track to snap six-day red streak

Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...

FedEx shares on track to record its seventh straight session of gains

Sundry Photography/iStock Editorial via Getty Images Global delivery firm FedEx (NYSE:FDX) shares are on track to record its seventh...